miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.

作者: Yuanqiang Lin , Kailiang Cheng , Tongtong Wang , Qian Xie , Minglong Chen

DOI: 10.1016/J.BIOPHA.2017.09.074

关键词: Cell cultureReal-time polymerase chain reactionmicroRNACell growthApoptosisThyroid cancerDownregulation and upregulationCancer researchBiologyIn vivo

摘要: Abstract Purpose The aims of this study were to test the influence miR-217 on proliferation, invasion, migration thyroid cancer and relevant mechanism. Method expression levels in tissues cell lines detected by quantitative real-time PCR (qRT-PCR).Cell Counting Kit-8, flow cytometer, wound healing, transwell invasion assays applied evaluate effect apoptosis, cells. luciferase reporter assay, qRT-PCR, western blot used identify target miR-217. Relative relationship level between AKT3 was analyzed tissues. Xenograft transplantation performed vivo . Results We found that significantly decreased lines. Significantly, associated with clinical stage lymph node metastasis. Function studies revealed overexpression cells inhibited migration, vitro , as well suppressed tumor growth Subsequently, identified a cancer. upregulated tissues, inversely correlated miR-217expression. Besides, efficiently abrogates suppressive caused Conclusion These data demonstrated suppressor role for development progression targeting AKT3, suggesting might be potential

参考文章(27)
Patricia Aragon Han, Chien-Hsiang Weng, Hunain T. Khawaja, Neeraja Nagarajan, Eric B. Schneider, Christopher B. Umbricht, Kenneth W. Witwer, Martha A. Zeiger, MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review. Thyroid. ,vol. 25, pp. 1322- 1329 ,(2015) , 10.1089/THY.2015.0193
H-W Hwang, J T Mendell, MicroRNAs in cell proliferation, cell death, and tumorigenesis. British Journal of Cancer. ,vol. 94, pp. 776- 780 ,(2006) , 10.1038/SJ.BJC.6603023
Avaniyapuram Kannan Murugan, Jianli Dong, Jingwu Xie, Mingzhao Xing, Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 Mutations in Thyroid Cancers Endocrine Pathology. ,vol. 22, pp. 97- 102 ,(2011) , 10.1007/S12022-011-9155-X
S Liu, R Semenciw, A-M Ugnat, Y Mao, Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects British Journal of Cancer. ,vol. 85, pp. 1335- 1339 ,(2001) , 10.1054/BJOC.2001.2061
GIULIA COSTANZA LEONARDI, SAVERIO CANDIDO, MAURIZIO CARBONE, VALERIA COLAIANNI, SEBASTIANO F. GAROZZO, DIANA CINÀ, MASSIMO LIBRA, microRNAs and thyroid cancer: biological and clinical significance (Review). International Journal of Molecular Medicine. ,vol. 30, pp. 991- 999 ,(2012) , 10.3892/IJMM.2012.1089
Renxiong Wei, Zhouming Deng, Jiajia Su, miR-217 targeting Wnt5a in osteosarcoma functions as a potential tumor suppressor Biomedicine & Pharmacotherapy. ,vol. 72, pp. 158- 164 ,(2015) , 10.1016/J.BIOPHA.2015.04.012
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, M. J. Thun, Cancer statistics, 2008. CA: A Cancer Journal for Clinicians. ,vol. 58, pp. 71- 96 ,(2008) , 10.3322/CA.2007.0010
T. Stokowy, B. Wojtaś, K. Fujarewicz, B. Jarząb, M. Eszlinger, R. Paschke, miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors: results of a meta-analysis. Hormone and Metabolic Research. ,vol. 46, pp. 171- 180 ,(2014) , 10.1055/S-0033-1363264
Albert de la Chapelle, Krystian Jazdzewski, MicroRNAs in Thyroid Cancer The Journal of Clinical Endocrinology and Metabolism. ,vol. 96, pp. 3326- 3336 ,(2011) , 10.1210/JC.2011-1004
QIANG WEN, JIE ZHAO, LIN BAI, TONGTONG WANG, HAISHAN ZHANG, QINGJIE MA, miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6 Oncology Reports. ,vol. 34, pp. 2202- 2210 ,(2015) , 10.3892/OR.2015.4165